Sjacobs, I believe is a disservice to ones' ban
Post# of 148161
(Total Views: 517)
Posted On: 01/03/2020 3:49:37 PM
Sjacobs,
I believe is a disservice to ones' bank account to sell any shares accounting for the potential of Leronlimab.
Either one believes or not. I am not trying to lecture anybody as one might need money for other pressing purposes, but, if this is just investing money and if one can't think of a better R/R investment, why sell one share ???
I won't.
In regards to price targets, the way I look at it, is to take-in the current information and make decisions. Time provides the right answers. Shall I sell at $10 ??? Well, it depends: if the market has already the outcome of data from Oncology and is in $10 for good reasons (out of fuel?) maybe yes. If its at $10 and still data from several Oncology indications is coming...well hell no, because the stock is going to maybe $100.
This is just an example with arbitrary numbers. One has to see the current valuation, see the current data, see the present market reaction, see the competition status, see the potential, see the accomplished and unaccomplished trials and indications and THEN, only THEN, make a decision on selling one share or all of them.
So, I am sitting waiting patiently …. time will tell. And then when the time comes I will think on selling, hopefully on triple digits.
I believe is a disservice to ones' bank account to sell any shares accounting for the potential of Leronlimab.
Either one believes or not. I am not trying to lecture anybody as one might need money for other pressing purposes, but, if this is just investing money and if one can't think of a better R/R investment, why sell one share ???
I won't.
In regards to price targets, the way I look at it, is to take-in the current information and make decisions. Time provides the right answers. Shall I sell at $10 ??? Well, it depends: if the market has already the outcome of data from Oncology and is in $10 for good reasons (out of fuel?) maybe yes. If its at $10 and still data from several Oncology indications is coming...well hell no, because the stock is going to maybe $100.
This is just an example with arbitrary numbers. One has to see the current valuation, see the current data, see the present market reaction, see the competition status, see the potential, see the accomplished and unaccomplished trials and indications and THEN, only THEN, make a decision on selling one share or all of them.
So, I am sitting waiting patiently …. time will tell. And then when the time comes I will think on selling, hopefully on triple digits.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼